Total Payments
$17,029
2024 Payments
$591.31
Companies
79
Transactions
1,062
Medicare Patients
4,880
Medicare Billing
$929,982
Payment Breakdown by Category
Food & Beverage$16,716 (98.2%)
Other$232.70 (1.4%)
Education$80.14 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,716 | 1,042 | 98.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $232.70 | 9 | 1.4% |
| Education | $80.14 | 11 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,756 | 109 | $0 (2022) |
| UCB, Inc. | $1,144 | 78 | $0 (2024) |
| ABBVIE INC. | $1,123 | 99 | $0 (2024) |
| Amgen Inc. | $936.89 | 54 | $0 (2024) |
| Biogen, Inc. | $873.24 | 69 | $0 (2023) |
| SK Life Science, Inc. | $606.25 | 29 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $580.74 | 36 | $0 (2022) |
| Mallinckrodt LLC | $548.51 | 40 | $0 (2018) |
| GENZYME CORPORATION | $525.96 | 26 | $0 (2023) |
| Avanir Pharmaceuticals, Inc. | $515.06 | 34 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $591.31 | 24 | SK Life Science, Inc. ($80.58) |
| 2023 | $1,624 | 92 | AbbVie Inc. ($193.19) |
| 2022 | $2,618 | 165 | ABBVIE INC. ($602.58) |
| 2021 | $2,757 | 172 | Allergan, Inc. ($565.96) |
| 2020 | $2,341 | 159 | Allergan, Inc. ($561.04) |
| 2019 | $1,607 | 92 | Avanir Pharmaceuticals, Inc. ($191.53) |
| 2018 | $2,864 | 160 | Mallinckrodt LLC ($312.68) |
| 2017 | $2,627 | 198 | UCB, Inc. ($249.60) |
All Payment Transactions
1,062 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/13/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $26.81 | General |
| 05/29/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Neurology | ||||||
| 05/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $32.04 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/24/2024 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Neuroscience | ||||||
| 04/19/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/18/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $36.58 | General |
| Category: Neurology | ||||||
| 04/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: PAIN | ||||||
| 04/03/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $27.45 | General |
| 04/02/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $18.17 | General |
| 04/01/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Neuroscience | ||||||
| 03/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.32 | General |
| Category: NEUROLOGY | ||||||
| 03/12/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Neurology | ||||||
| 03/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: PAIN | ||||||
| 02/14/2024 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Neuroscience | ||||||
| 02/13/2024 | Sandoz Inc. | — | Food and Beverage | In-kind items and services | $17.00 | General |
| 02/13/2024 | Amneal Pharmaceuticals LLC | RYTARY (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: NEUROLOGY | ||||||
| 01/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/18/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/16/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $33.52 | General |
| Category: Spinal Cord Stimulator | ||||||
| 01/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $18.85 | General |
| Category: NEUROLOGY | ||||||
| 01/09/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: Neurology | ||||||
| 01/08/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $26.32 | General |
| 12/19/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.80 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,247 | 19,770 | $795,818 | $240,866 |
| 2022 | 12 | 1,240 | 18,402 | $812,910 | $242,562 |
| 2021 | 14 | 1,223 | 17,302 | $795,581 | $241,773 |
| 2020 | 14 | 1,170 | 15,508 | $591,156 | $204,781 |
Total Patients
4,880
Total Services
70,982
Medicare Billing
$929,982
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 38 | 18,100 | $271,500 | $88,748 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 605 | 932 | $269,220 | $80,450 | 29.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 202 | 202 | $86,592 | $23,082 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 179 | 236 | $48,212 | $14,653 | 30.4% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 30 | 79 | $32,390 | $8,453 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 61 | 64 | $23,900 | $7,925 | 33.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 42 | 42 | $22,958 | $6,608 | 28.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 14 | 14 | $16,450 | $4,507 | 27.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $10,222 | $2,465 | 24.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 19 | 19 | $5,510 | $1,611 | 29.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 11 | 32 | $5,600 | $1,393 | 24.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 14 | $2,584 | $821.92 | 31.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 17 | $680.00 | $149.66 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 621 | 1,021 | $301,195 | $90,336 | 30.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 32 | 16,700 | $250,500 | $80,017 | 31.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 197 | 197 | $86,680 | $22,326 | 25.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 79 | 85 | $33,575 | $11,011 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 161 | $33,005 | $9,599 | 29.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 22 | 65 | $26,650 | $7,300 | 27.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 39 | 39 | $21,450 | $5,821 | 27.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 14 | 14 | $16,450 | $4,759 | 28.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 30 | 30 | $16,950 | $4,362 | 25.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 11 | 11 | $10,835 | $3,295 | 30.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 20 | 20 | $8,800 | $2,042 | 23.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 14 | 20 | $3,500 | $829.26 | 23.7% |
About Dr. Brian Beck, MD
Dr. Brian Beck, MD is a Neurology healthcare provider based in Gilbert, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2010. The National Provider Identifier (NPI) number assigned to this provider is 1154642205.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Beck, MD has received a total of $17,029 in payments from pharmaceutical and medical device companies, with $591.31 received in 2024. These payments were reported across 1,062 transactions from 79 companies. The most common payment nature is "Food and Beverage" ($16,716).
As a Medicare-enrolled provider, Beck has provided services to 4,880 Medicare beneficiaries, totaling 70,982 services with total Medicare billing of $929,982. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Gilbert, AZ
- Active Since 06/11/2010
- Last Updated 02/26/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1154642205
Products in Payments
- BOTOX (Biological) $1,520
- Aimovig (Biological) $879.98
- UBRELVY (Drug) $620.97
- ACTHAR (Biological) $599.09
- Briviact (Drug) $554.71
- NUPLAZID (Drug) $510.06
- NURTEC ODT (Drug) $439.60
- APTIOM (Drug) $423.96
- EMGALITY (Drug) $370.51
- AUBAGIO (Drug) $332.74
- AIMOVIG (Biological) $310.76
- NUEDEXTA (Drug) $305.25
- VNS Therapy (Device) $299.71
- ACTIVA (Device) $280.32
- Hizentra (Biological) $279.33
- Neupro (Drug) $265.09
- AJOVY (Biological) $259.72
- RYTARY (Drug) $250.87
- Gamunex-C (Biological) $249.72
- ONZETRA Xsail (Drug) $228.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Gilbert
William Grainger, Md, MD
Neurology — Payments: $442,194
Neurology $442,194
Jonathan Hodgson, Do, DO
Neurology — Payments: $366,071
Neurology $366,071
Paarth Shah, M.d, M.D
Neurology — Payments: $238,823
Neurology $238,823
Kan Yu, Md,Phd, MD,PHD
Neurology — Payments: $39,149
Neurology $39,149
Dr. Mildred Dejesus, Md, MD
Neurology — Payments: $10,414
Neurology $10,414
Virgilio Salanga, Md, MD
Neurology — Payments: $1,516
Neurology $1,516